After over five-and-a-half years of R&D and associated efforts, I am proud to say that I have received the patent on my treatment technology for Alzheimer’s Disease: U.S. Patent 9,037,268
As I mentioned in my statement to the press, I made the decision with my company to forgo patent licensing fees for R&D. This is too important of an innovation to keep it bottled up or to inhibit the early stages of medical research. Too many people are suffering. Too many people are dying.
Alzheimer’s Disease is an incurable disease that affects 5.3 million people in the U.S. and nearly 44 million worldwide.
My patented technology is based on years of research by scientists regarding the effects of radio waves on the human brain. Recent studies exposed RF energy to mice that have been genetically modified to exhibit Alzheimer’s disease. Mice and humans share 95% of their genes, providing an appropriate reference for comparative studies.
One study in particular was the research conducted by the University of South Florida. (The research study, as published in the Journal of Alzheimer’s Disease, is available at my company’s special Web site www.AlzheimersTreatmentInvention.com.) The following is from the Abstract of the published study: “Although caution should be taken in extrapolating these mouse studies to humans, we conclude that EMF [electromagnetic field / radio frequency energy] exposure may represent a non-invasive, non-pharmacologic therapeutic against Alzheimer’s disease….” The study concludes “… we believe that the current lack of an effective therapeutic against [Alzheimer’s Disease], in concert with this study’s surprising findings, justifies EMF exposure as a non-invasive, non-pharmacologic approach worthy of vigorous investigation.”
For more information, including research references, the patent, the full press announcement, and links to TV, radio, and other media / new reports, please visit www.AlzheimersTreatmentInvention.com.
Entrepreneurs rocked the house last night at Stamford’s historic Palace Theatre. The Shark Tank-style pitch competition featured Connecticut-based entrepreneurs and startups. Kudos to these creative minds that help power our State’s backbone of business innovation.
The event was sponsored and facilitated by CTNext, a core driver and resource provider of Connecticut’s innovation ecosystem. Find out more here: www.CTNext.com
Yep: Our entire electrical grid, orbiting satellites, Internet — the mainstays of modern life — were almost wiped out on July 23, 2012.
This is not hyperbole. It almost happened. And scientists believe that the odds of a solar storm with enough intensity to disrupt our lives over the next 10 years is 12%.
With all of the crises going on in the world, this little bit of news slipped through the cracks of the general media. But it got the attention of lots of scientists and astronomers.
If you want to know how close we came, check out http://bit.ly/1jYtzzb
Image courtesy of the Associated Press
You know what they say about all work and no play. So I took a little time out from business to play some classic rock with my ol’ buddy Arnold “Arnie” Aranci and his sons. The goal: Raise money for our hometown’s food pantry at the inaugural “Hamstock” event. We way exceed our goal, raising $1,500.
Enjoy the following HD YouTube videos:
Last Dance With Mary Jane (Tom Petty). Arnold “Arnie” Aranci, Eric Knight, Christopher Aranci, Anthony Aranci:
Takin’ Care Of Business (Bachman Turner Overdrive). Arnold “Arnie” Aranci, Eric Knight, Christopher Aranci, Anthony Aranci:
Johnny B Goode (Chuck Berry). Arnold “Arnie” Aranci, Eric Knight, Christopher Aranci, Anthony Aranci:
Download and read the excellent perspective on the Affordable Health Care Act, a.k.a., “Obamacare” — entitled “Health Reform: Seven Things You Need To Know” — by clicking on this link.
5.2 million Americans have Alzheimer’s disease; it is the sixth leading cause of death in the U.S. It is a terrible disease that rips apart the fabric of families.
The disease also drains the American economy by over $200 billion per year in health-care costs. It’s an international crisis, as well, affecting 35 million people, worldwide.
I have been working on my invention for over three-and-a-half years. Until my patent issues, I can’t describe the system in any detail. I can say that it uses radio waves in tandem with aerospace-inspired technology. And my goal is to connect with one or more industry partners with the wherewithal to take the next steps — such as further laboratory research and, ultimately, clinical trials.
To the science and medical community, and other potential business partners, the following is a special phone number for confidential discussions: (860) 993-1310. Similarly, here is a special e-mail address: email@example.com
To stay up to date on any developments, I encourage anyone reading this to follow my company’s Twitter feed here: @alzinvention
*** Quick Note *** I am proud to say I am getting news coverage from all over — local to worldwide. Here’s a news article from the Hartford Business Journal: http://www.hartfordbusiness.com/article/20130917/NEWS01/130919918/1002 And here’s an article from Europe: http://uk.finance.yahoo.com/news/cure-alzheimers-disease-renowned-inventor-144500825.html
Nothing beats a steak cooked on an open flame. Nothing. But what if you’re short on time but still want that grilled-flame flavor? Well, I’ve been experimenting. (Yes, I still play with my food!) Just take your steaks, put them on a microwave-safe plate, and cover them with a piece of white paper towel (“Bounty” etc.). Pre-cook them in the microwave on high for about 2.5 minutes per total pound of meat. While the microwave is doing its job, heat up your grill. Get it nice and hot. (I get the temperature to about 400 degrees F.) Then pop the pre-cooked steaks on the grill. Cook the steaks for three to four minutes on one side — and then flip. Cook for another minute or two. Presto! You’ll be really, really surprised at the flavor. I am a grilled-steak aficionado, but I’m not sure if I can tell the difference.
FRINGE BENEFIT: If you are concerned about the potential carcinogens caused by grilling — heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) — then you’ll also be doing yourself and your family a favor with this combination cooking method, as it dramatically shortens the time on the grill. BTW, the photos in this post are rib-eye steaks that me and my wife, Elsie, recently cooked with this super-quick method. And they were delicious!
(BBC) Scientists took cells from a cow and, at an institute in the Netherlands, turned them into strips of muscle which they combined to make a patty. Researchers say the technology could be a sustainable way of meeting what they say is a growing demand for meat. An independent study found that lab grown beef uses 45% less energy than the average global representative figure for farming cattle. It also produces 96% fewer greenhouse gas emissions and requires 99% less land. For the complete article, click here. Image courtesy of the BBC
Spacewalking partner Chris Cassidy, a U.S. astronaut, took a look: “It’s a lot of water. His hair is saturated. It’s in his eyes as well as his nose and mouth.”
Mission Control was alarmed. NASA quickly aborted the spacewalk, cut it short by five hours. Parmitano and Cassidy were ordered back to the U.S. Quest airlock, where they would be out of the deadly vacuum environment in low Earth orbit, and into the relative safety of the space station.
The tide kept rising in Parmitano’s helmet during his 20-minute retreat to the airlock. And yes, NASA said he was in danger of drowning.
“Imagine you’re in a fish bowl,” said David Korth, NASA’s lead spacewalk flight director. “So, go stick your head in a fish bowl and try to walk around, and that’s not anything you would take lightly. And certainly, (spacewalking) is dangerous already.”
Parmitano could not hear or respond to questions after he reentered the airlock.
“Hey, Luca, from Houston, how’re you doing? Give us a status,” astronaut Shane Kimbrough said from Mission Control.
“Luca, did you hear that?” Cassidy asked.
“Squeeze my hand if you’re fine,” Cassidy said, peering into his crewmate’s visor.
“I’m trying to see him,” Cassidy said. “He looks fine. He looks miserable, but OK.”
NASA is investigating. The initial suspect, a drinking water bag, no longer is thought to be the culprit. Jones, the veteran spacewalker, said his best guess is the leak came from Parmitano’s astronaut underwear.
Astronauts don form-fitting garments called Liquid Cooling and Ventilation Garments. They are cooled by chilled water lines running throughout. Jones suspects a rupture in a cooling line near Parmitano’s neck.
“The closest water line to where he was experiencing (trouble) is in the neck area of the LCVG,” Jones said.
For the complete article, click here. Image courtesy of AP/NASA
As part of my ongoing LED light bulb reviews, the following is my real-world testing of the EcoSmart 13-watt (60-watt-equivalent) LED bulb. In case you haven’t noticed, traditional 100w & 75w incandescent bulbs have been phased out (all manufacturing in the U.S. has ceased). Why? Because although America has just 5% of the world’s population, we use 26% of the world’s energy. And lighting is a major culprit. I have been testing all sorts of replacement bulbs — so you don’t have to. Skip the compact fluorescents and head straight to the new generation of LEDs. They’re “instant on,” dimmable (most of them), and light a room just as good — or even better — than traditional bulbs. The best bulb I’ve found so far is the “EcoSmart” 60-watt-equivalent “bright white” LED. Although packaged as a 60-watt replacement, it has nearly the same number of “lumens” (amount of visible light) as a 75-watt incandescent. It will last 25x longer than an incandescent bulb — up to 23 years! And only uses 13 watts of power. The color of the light is pleasing, too — a very natural, bright white. Bottom line: It will save you up to $161 vs. a regular 75-watt bulb. And it will keep working for a quarter century. It’s $9.95 at Home Depot — a great deal. I’ve included a photo so you can spot it quickly in the aisle. Suggestion: Buy one and try it. I bet you’ll like it! Let me know…
Results: Over the 4-year study period, there were 121,084 firearm fatalities. The average state-based firearm fatality rates varied from a high of 17.9 (Louisiana) to a low of 2.9 (Hawaii) per 100,000 individuals per year. Annual firearm legislative strength scores ranged from 0 (Utah) to 24 (Massachusetts) of 28 possible points. States in the highest quartile of legislative strength (scores of >9) had a lower overall firearm fatality rate than those in the lowest quartile (scores of <2) (absolute rate difference, 6.64 deaths/100,000/y; age-adjusted incident rate ratio [IRR], 0.58; 95% CI, 0.37-0.92). Compared with the quartile of states with the fewest laws, the quartile with the most laws had a lower firearm suicide rate (absolute rate difference, 6.25 deaths/100,000/y; IRR, 0.63; 95% CI, 0.48-0.83) and a lower firearm homicide rate (absolute rate difference, 0.40 deaths/100,000/y; IRR, 0.60; 95% CI, 0.38-0.95).
Conclusions and Relevance: A higher number of firearm laws in a state are associated with a lower rate of firearm fatalities in the state, overall and for suicides and homicides individually. As our study could not determine cause-and-effect relationships, further studies are necessary to define the nature of this association.
Eric W. Fleegler, MD, MPH; Lois K. Lee, MD, MPH; Michael C. Monuteaux, ScD; David Hemenway, PhD; Rebekah Mannix, MD, MPH
JAMA Intern Med. 2013;():1-9. doi:10.1001/jamainternmed.2013.1286.
Published online March 6, 2013
(AP) RIO DE JANEIRO – Doctors say a 24-year-old construction worker survived after a 6-foot metal bar fell from above and pierced his skull. Luiz Alexandre Essinger, chief of staff at Rio de Janeiro’s Miguel Couto Hospital, said doctors successfully withdrew the iron bar from Eduardo Leite’s skull during a five-hour surgery. “He was taken to the operating room, his skull was opened, they examined the brain and the surgeon decided to pull the metal bar out from the front in the same direction it entered the brain.” Essinger said.
The non-partisan Kaiser Family Foundation has prepared a superb summary of the Affordable Care Act. No hype. No political spin. No mis-information.
Read about: The individual mandate. Employer requirements. Prevention and wellness programs. How public programs are expanded. Premiums. Cost-sharing subsidies. Related tax changes. Health insurance exchanges. Impacts on private insurance. State role. Cost containment. Improving quality and health care system performance. Nutritional information required to be disclosed by restaurant chains. Long-term care. Coverage and financing.
Here’s the link to the KFF summary of health care reform as provided by the Affordable Care Act: http://www.kff.org/healthreform/upload/8061.pdf
F.Y.I., regarding “coverage and financing,” the KFF summary reports:
The Congressional Budget Office (CBO) estimates the new health reform law will provide coverage to an additional 32 million when fully implemented in 2019 through a combination of the newly created Exchanges and the Medicaid expansion.
CBO estimates the cost of the coverage components of the new law to be $938 billion over ten years. These costs are financed through a combination of savings from Medicare and Medicaid and new taxes and fees, including an excise tax on high-cost insurance, which CBO estimates will raise $32 billion over ten years. CBO also estimates that the health reform law will reduce the deficit by $124 billion over ten years.
Medical professionals seldom use the world “miracle” with any treatment. But those are precisely the words being used by the scientific community in regards to T-DM1, a new drug for women with Stage 3 or Stage 4 (metastatic) breast cancer.
As reported in today’s MSN HEALTH:
“This week there was big news for HER2-positive women: a dramatic announcement about T-DM1, an experimental drug that’s been in clinical trials since January. Known colloquially as ‘super Herceptin’ by the women taking it, T-DM1 is an unusual joint project between two companies, Genentech, which makes the targeted antibody trastuzumab (Herceptin), and ImmunoGen which contributed its cancer-killing agent DM1.
“Oncologists don’t like the term ‘miracle drug,’ and try not to use it — but the word miracle was in fact used when researchers presented results of a Phase II trial of T-DM1 at the Breast Cancer Symposium in San Antonio, Texas, last Tuesday.”
For the full article, visit this link: http://on-msn.com/o1ifjV
Here’s another excellent article from ABC NEWS HEALTH: http://abcn.ws/K51YWL
Let’s all hope T-DM1 lives up to the promise seen in the clinical trials, to give women a powerful new weapon in the fight against this terrible disease.
Image courtesy ABC NEWS and Getty Images
The icky stuff you see floating on the top of stagnant water may become the latest weapon in spotting cancer cells circulating in a bloodstream. That’s the bottom line from renowned scientist, Yoshinobu Baba, Ph.D. , and his research with the pond-scum microbe called Euglena.
According to an article from the American Chemical Society, “Baba’s team turned to Euglena in an effort to solve the medical problem of detecting the minute number of cancer cells that break off from the original, or primary, tumor site and travel through the bloodstream. Those cells, termed circulating tumor cells (CTCs), enable cancer to spread, or metastasize, and start growing at distant sites in the body. Metastasis is the main reason why cancer can be such a difficult disease to treat. Detecting those cells would raise a red flag so that doctors could treat or more intensively monitor patients.”
Baba’s novel technique uses Euglena to help detect those minute cancer cells. It’s an ingenious combination of scientific brilliance and Mother Nature.
For the complete article, with the scientific premise behind the technique, visit the American Chemical Society’s Web site at this link: http://bit.ly/GRiV8R
Image courtesy of Yoshinobu Baba
(The Guardian / UK) “Taking a low dose [75-milligram] of aspirin each day may prevent cancer and stop it spreading, according to three papers to be published in leading medical journals on Wednesday. It could also possibly have a use as a treatment for the disease.
“Dr Peter Rothwell from Oxford University and the John Radcliffe hospital and colleagues, the authors of the studies in the Lancet and Lancet Oncology have previously shown that long-term daily aspirin, for 10 years or so, reduces the risk of colorectal (bowel) cancer and other common cancers, but some experts have voiced concerns over potential long-term side-effects, because aspirin can cause stomach bleeding.
“The new studies reinforce aspirin’s claim to be a weapon against cancer. They show that taking daily low-dose pills for just three years can reduce your risk of cancer by about a quarter — 23% for men and 25% for women. The risk of dying of cancer is cut by 15% — and by 37% for those who take aspirin for longer than five years.
“The second study found that aspirin helped prevent the spread of cancer — or metastasis — to other organs, which is a serious threat to the patient’s survival. Aspirin reduced the proportion of cancers that spread instead of staying localised by 48%.
“The drug also reduced the risk of being diagnosed with a solid cancer that had already spread by 31%. For patients initially diagnosed with a local cancer, the risk of later metastasis was reduced by 55%.”
For the complete article, visit http://bit.ly/GDovty
Image courtesy of Scot Frei / Corbis
ABC News / Australian 9NEWS: “A U.S. transgender woman has been charged with practising cosmetic surgery without a licence after she injected a patient’s buttocks with a cocktail of substances including cement and [tire] sealant, police say.
“Oneal Ron Morris, 30, was arrested last Friday for conducting a botched butt implant at a Miami home last May, ABC reports. Police said Morris shot a mixture of cement, glue, mineral oil and ‘Fix-A-Flat’ [tire] mender into the woman’s buttocks and then sealed the amateur incision with super glue.
“Morris, who appears to have an ‘enhanced’ rear end herself from police photos, first met her victim to discuss the procedure in May 2010. ‘They agreed on the price of $700 for the procedure, which was intended for cosmetic purposes,’ Sgt William Bamford told ABC. But the patient soon complained of serious pains in her abdomen and throughout her body, and was hospitalized.”
For the complete head-shaking story, visit http://bit.ly/rwQ7if
Police photo of Oneal Ron Morris courtesy of ABC News / Australian 9NEWS
Just when you thought scientific research couldn’t get any more bizarre, here’s a new benchmark: Researchers at the University College London have apparently discovered a link between the number of Facebook friends and the size particular of brain regions, such as the amygdala, where memory and emotion are processed.
The researchers do not suggest whether they believe it was Facebook activity that increased the size of these portions of the brain — or — if someone’s amygdala size, for instance, influences a person’s desire to acquire Facebook friends.
If you’d like to know more about this unusual study, check out the Reuter’s report here: http://reut.rs/rm6Apb. And, yes, feel free to share the details with your friends on Facebook.
Image courtesy of Reuters
According to the Associated Press, “IBM’s supercomputer system, best known for trouncing the world’s best ‘Jeopardy!’ players on TV, is being tapped by one of the nation’s largest health insurers to help diagnose medical problems and authorize treatments. WellPoint Inc., which has 34.2 million members, will integrate Watson’s lightning speed and deep health care database into its existing patient information, helping it choose among treatment options and medicines.”
I have mixed feelings about this development. We all remember how the HAL 9000 turned against the astronauts in 2001: A Space Odyssey. Sure, that was science fiction. But so were artificial satellites when they were envisioned a decade before Sputnik by the master science-fiction writers Arthur C. Clarke and Robert Heinlein. Computers are marvelous tools. But good ol’ fashion intuition, by a seasoned physician, is (with current technology) impossible to replicate.
For the full AP article, visit http://bit.ly/n621oi
Photo courtesy AP and IBM
According to a news report from the BBC, the world’s smallest electric motor “could have applications in both nanotechnology and in medicine….
“The butyl methyl sulphide molecule was placed on a clean copper surface, where its single sulfur atom acted as a pivot…. As well as forming a part of the tiniest machines the world has ever seen, such minute mechanics could be useful in medicine — for example, in the controlled delivery of drugs to targeted locations.
“The next thing to do is to…couple it to other molecules, lining them up next to one another so they’re like miniature cog-wheels.”
To read the complete BBC report, visit http://bbc.in/qZKTg4
The Food and Drug Administration (FDA) has approved a new drug — Zalboraf — that has shown effectiveness in treating a challenging, and in some cases fatal, form of skin cancer. This is the second melanoma treatment to be approved this year; in March, the FDA approved the drug Yervoy. For more information, review the article at http://bit.ly/pxhyhW
As reported in the European Respiratory Journal, dogs can be trained to sniff the breath of patients and confirm cases of lung cancer.
The four dogs in the study were two German shepherds, a Labrador retriever, and an Australian shepherd. The dogs’ overall accuracy was 71%.
For additional details, take a look at the following excellent report in today’s Daily Mail: http://bit.ly/q0ChrB
The Los Angeles Times reports that MIT scientists have created a drug that “…takes advantage of a molecule called double-stranded RNA, which is produced by many, many viruses when they infect mammalian cells. Uninfected, our cells usually don’t make this double-stranded RNA, and to some extent our cells have evolved to recognize this structure and respond. Just not potently enough. The drug created by the MIT team can enter mammalian cells and is engineered to induce the cells to commit suicide if — and only if — they contain double-stranded RNA.”
The scientists’ preliminary studies were effective against 15 virus types, including Dengue fever and H1N1. It will be interesting to see if the next phase of research can replicate this significant level of success.
For the full LA Times article, visit http://lat.ms/q077Jb
“Scientists for the first time have used gene therapy to successfully destroy cancer tumors in patients with advanced disease — a goal that has taken 20 years to achieve. Researchers at the University of Pennsylvania engineered patients’ own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. The results provide ‘a tumor-attack roadmap for the treatment of other cancers,’ including those of the lung and ovaries as well as myeloma and melanoma, researchers said.”
For the complete article, visit http://reut.rs/p3tGN9
Photo courtesy of Reuters
You’re essentially looking over my shoulder as I write, think, create, invent, and — in general — ponder the world around us. Feel free to peruse my writings and chime in as you’re so inspired. I encourage spirited debate.
This is a specially crafted multi-pronged conduit. Everything I type feeds parallel simultaneous streams to Twitter, Facebook, LinkedIn, and my e-mail broadcast system. It’s a global tightrope without a net. Oh, my.
No topic is off limits. If you’re looking for a site that is “politically correct,” you’ve come to the wrong place. Hit the back button on your browser now.
Lots and lots of new features are coming online. They’re all in various stages of development. You’ll soon see innovative things I’m working on — such as a live, streaming, two-way “TV channel” of sorts where you’ll be able to interact with me (audio, video, text) in real time as I type here in front of my computer.
This is my platform to push the boundaries of technology in every dimension.
Hang on tight. We may achieve orbit. Or we may sail off a cliff. But the ride will be exhilarating.